Rocco Sciarrillo

1.1k total citations
17 papers, 584 citations indexed

About

Rocco Sciarrillo is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Rocco Sciarrillo has authored 17 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in Rocco Sciarrillo's work include RNA modifications and cancer (6 papers), RNA Research and Splicing (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Rocco Sciarrillo is often cited by papers focused on RNA modifications and cancer (6 papers), RNA Research and Splicing (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Rocco Sciarrillo collaborates with scholars based in Netherlands, Italy and United States. Rocco Sciarrillo's co-authors include Elisa Giovannetti, Jacqueline Cloos, Gertjan J.L. Kaspers, Gerrit Jansen, Anna Wojtuszkiewicz, Yehuda G. Assaraf, Godefridus J. Peters, Niccola Funel, Carlotta Granchi and Filippo Minutolo and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Rocco Sciarrillo

15 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rocco Sciarrillo Netherlands	11	408	236	151	89	44	17	584
Xuhong Fu China	12	488 1.2×	137 0.6×	172 1.1×	87 1.0×	77 1.8×	12	712
Radosław Polański United Kingdom	12	428 1.0×	268 1.1×	186 1.2×	111 1.2×	43 1.0×	14	602
Cristina Mir Spain	14	547 1.3×	309 1.3×	245 1.6×	74 0.8×	59 1.3×	18	792
Xinpeng Shi China	11	341 0.8×	211 0.9×	140 0.9×	46 0.5×	39 0.9×	17	522
Joëlle Collignon Belgium	12	383 0.9×	257 1.1×	285 1.9×	127 1.4×	46 1.0×	59	699
Özge Saatci United States	18	461 1.1×	295 1.3×	230 1.5×	107 1.2×	65 1.5×	29	749
Yoelsis Garcia‐Mayea Spain	15	574 1.4×	315 1.3×	251 1.7×	71 0.8×	61 1.4×	17	823
Mona Malz Germany	13	434 1.1×	136 0.6×	131 0.9×	38 0.4×	35 0.8×	13	568
Phuong Nguyen United States	7	532 1.3×	354 1.5×	159 1.1×	129 1.4×	43 1.0×	10	728

Countries citing papers authored by Rocco Sciarrillo

Since Specialization

Citations

This map shows the geographic impact of Rocco Sciarrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco Sciarrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco Sciarrillo more than expected).

Fields of papers citing papers by Rocco Sciarrillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocco Sciarrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco Sciarrillo. The network helps show where Rocco Sciarrillo may publish in the future.

Co-authorship network of co-authors of Rocco Sciarrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Rocco Sciarrillo. A scholar is included among the top collaborators of Rocco Sciarrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocco Sciarrillo. Rocco Sciarrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Sciarrillo, Rocco, Annalisa Comandatore, Bing Wang, et al.. (2024). Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target. International Journal of Biological Sciences. 20(8). 3173–3184. 4 indexed citations

2.

Werf, Inge van der, Anna Wojtuszkiewicz, Huilan Yao, et al.. (2021). SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia. Leukemia. 35(9). 2698–2702. 8 indexed citations

3.

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.. (2020). The role of alternative splicing in cancer: From oncogenesis to drug resistance. Drug Resistance Updates. 53. 100728–100728. 181 indexed citations

4.

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Irsan Kooi, et al.. (2020). Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation. Cancers. 12(3). 723–723. 17 indexed citations

5.

Komor, Malgorzata A., et al.. (2020). Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 21(12). 4192–4192. 13 indexed citations

6.

Hassouni, Btissame El, Rocco Sciarrillo, Mina Maftouh, et al.. (2019). Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2. 3082–3082. 1 indexed citations

7.

Hassouni, Btissame El, Rocco Sciarrillo, Mina Maftouh, et al.. (2019). Abstract 3082: Targeting hypoxic pancreatic cancer cells with glucose conjugated lactate dehydrogenase inhibitor NHI-Glc-2. Cancer Research. 79(13_Supplement). 3082–3082.

8.

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.. (2018). Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma. EBioMedicine. 39. 215–225. 47 indexed citations

9.

Cavazzoni, Andrea, Silvia La Monica, Roberta Alfieri, et al.. (2017). Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN. Oncotarget. 8(32). 53068–53083. 22 indexed citations

10.

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Irsan Kooi, et al.. (2016). Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models. Journal of Visualized Experiments. 21 indexed citations

11.

Sciarrillo, Rocco, Anna Wojtuszkiewicz, Irsan Kooi, et al.. (2016). Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in <em>In Vitro</em> Cancer Models. Journal of Visualized Experiments.

12.

Galvani, Elena, Jing Sun, Leticia G. León, et al.. (2015). NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor. Oncotarget. 6(40). 42717–42732. 26 indexed citations

13.

Sciarrillo, Rocco, Filippo Minutolo, Godefridus J. Peters, & Elisa Giovannetti. (2014). Lactate dehydrogenase acetylation adds another piece to the puzzle of metabolic reprogramming in pancreatic cancer. Pure Amsterdam UMC. 3(2). 64–66. 1 indexed citations

14.

León, Leticia G., Maria Gemelli, Rocco Sciarrillo, et al.. (2014). Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells. Current Drug Targets. 15(14). 1331–1340. 15 indexed citations

15.

Maftouh, Mina, Abolfazl Avan, Rocco Sciarrillo, et al.. (2013). Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. British Journal of Cancer. 110(1). 172–182. 142 indexed citations

16.

Giovannetti, Elisa, Mariëtte Labots, Henk Dekker, et al.. (2012). Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells. Current Pharmaceutical Design. 19(5). 927–939. 25 indexed citations

17.

Granchi, Carlotta, Sarabindu Roy, Tiziano Tuccinardi, et al.. (2011). N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation. European Journal of Medicinal Chemistry. 46(11). 5398–5407. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact